Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
Mario Castro(University of Kansas), Alberto Papi(University of Ferrara), Celeste Porsbjerg(Frederiksberg Hospital), Njira Lugogo(Michigan Medicine), Christopher E Brightling(NIHR Leicester Biomedical Research Centre), Francisco Javier González‐Barcala(Complejo Hospitalario Universitario de Santiago), Arnaud Bourdin(Centre National de la Recherche Scientifique), Мykola Ostrovskyy(Ivano-Frankivsk National Medical University), Maria Staevska(Medical University of Sofia), Pai-Chien Chou(Taipei Medical University Hospital), Liliana Duca, Ana Margarida Pereira(CUF Porto Hospital), Charles Fogarty(Spartanburg Regional Medical Center), Rufai Nadama(King Khalid University Hospital), Mei Zhang(Sanofi (United States)), Amelie Rodrigues, Xavier Soler(Regeneron (United States)), Harry Sacks(Regeneron (United States)), Yamo Deniz(Regeneron (United States)), Paul J. Rowe(Sanofi (United States)), Lucía De Prado Gómez(Sanofi (Spain)), Juby A Jacob-Nara(Sanofi (United States))
Cited by 66Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis